LANDRISCINA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 8.704
EU - Europa 7.398
AS - Asia 5.976
SA - Sud America 932
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 14
Totale 23.115
Nazione #
US - Stati Uniti d'America 8.583
CN - Cina 2.367
IE - Irlanda 2.287
SG - Singapore 1.968
UA - Ucraina 1.567
SE - Svezia 966
BR - Brasile 766
RU - Federazione Russa 752
HK - Hong Kong 635
IT - Italia 471
FI - Finlandia 328
DE - Germania 307
TR - Turchia 304
FR - Francia 289
VN - Vietnam 272
GB - Regno Unito 198
IN - India 173
AR - Argentina 65
CA - Canada 62
BE - Belgio 57
BD - Bangladesh 50
IQ - Iraq 36
MX - Messico 35
NL - Olanda 31
PL - Polonia 30
AT - Austria 28
CZ - Repubblica Ceca 27
JP - Giappone 26
ZA - Sudafrica 24
EC - Ecuador 22
VE - Venezuela 22
ID - Indonesia 20
EU - Europa 18
CO - Colombia 17
PK - Pakistan 16
ES - Italia 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
JO - Giordania 12
MA - Marocco 12
PY - Paraguay 12
AL - Albania 10
AU - Australia 10
CL - Cile 10
LT - Lituania 10
SA - Arabia Saudita 10
AZ - Azerbaigian 8
PE - Perù 8
UY - Uruguay 8
IR - Iran 7
NP - Nepal 7
TN - Tunisia 7
EG - Egitto 6
DO - Repubblica Dominicana 5
LB - Libano 5
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
MY - Malesia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
PA - Panama 2
TH - Thailandia 2
AM - Armenia 1
BZ - Belize 1
CI - Costa d'Avorio 1
EE - Estonia 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
MW - Malawi 1
NA - Namibia 1
NG - Nigeria 1
NO - Norvegia 1
Totale 23.106
Città #
Dublin 2.285
Chandler 1.338
Jacksonville 1.110
Singapore 880
Dearborn 754
Nyköping 643
Hong Kong 631
Nanjing 581
Ashburn 557
Dallas 430
Beijing 395
Santa Clara 305
Princeton 248
Nanchang 221
Wilmington 216
New York 212
San Mateo 199
Munich 164
Boardman 144
Moscow 121
Shenyang 115
Ann Arbor 111
Kunming 109
Des Moines 106
Hebei 106
Ho Chi Minh City 105
Helsinki 104
Tianjin 83
The Dalles 79
Jiaxing 78
Woodbridge 78
Los Angeles 76
Changsha 69
São Paulo 66
Brussels 55
Jinan 47
Hangzhou 46
Foggia 40
Hanoi 39
Turku 37
Guangzhou 36
Seattle 35
London 34
Rio de Janeiro 34
Zhengzhou 30
Council Bluffs 29
Washington 26
Belo Horizonte 25
Ningbo 24
Nuremberg 23
Warsaw 23
Brno 22
Chicago 22
San Francisco 22
Toronto 21
Brooklyn 20
Shanghai 20
Auburn Hills 19
Norwalk 19
San Jose 19
Bari 18
Lanzhou 18
Taizhou 18
Rome 16
Frankfurt am Main 15
Milan 15
Montreal 15
Vienna 15
Boston 14
Brasília 14
Changchun 14
Orange 14
Tokyo 14
Da Nang 13
Fuzhou 13
Hilden 13
Palermo 13
Tashkent 13
Amman 12
Buenos Aires 12
Dong Ket 12
Falls Church 12
Pune 12
Ankara 11
Atlanta 11
Baghdad 11
Curitiba 11
Dhaka 11
Haiphong 11
Johannesburg 11
Redwood City 11
Saint Petersburg 11
Charlotte 10
Phoenix 10
Wuhan 10
Chennai 9
Jakarta 9
Matera 9
Mexico City 9
Quito 9
Totale 13.985
Nome #
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits 157
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: Do we have a major breakthrough? 156
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 147
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 139
Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine. 135
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. 134
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 131
Altered gene expression of MnSOD in Hepatocarcinomas. 127
Anti-tumor Activity of non-Nucleosidic Reverse Transcriptase Inhibitors 127
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 127
FUNCTIONAL CHARACTERIZATION OF TRAP1 PATHWAY IN MULTIDRUG RESISTANCE IN HUMAN COLORECTAL CARCINOMA 126
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines 125
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 125
Ruolo del signaling dell’EGF nel fenotipo angiogenetico del carcinoma indifferenziato della tiroide: implicazioni terapeutiche 123
Schedule-Dependent Activity of the 5-Fluorouracil and Irinotecan Combination in the Treatment of Human Colorectal Cancer: In Vitro Evidences and a Phase I Dose-escalating Clinical Trial. 122
The role of human chorionic gonadotropin as tumor marker: Biochemical and clinical aspects 121
Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fiber in vitro. 120
THE CALCIUM-BINDING PROTEIN S100A13 CORRELATES WITH AN ANGIOGENIC PHENOTYPE IN MALIGNANT MELANOMA 120
A role of endogenous Reverse Transcriptase activity in embryo development and in tumor cell growth and differentiation 119
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 119
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 118
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 118
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma 117
bFGF in the angiogenesis of human colorectal cancer. 116
Gli inibitori della retrotrascrittasi inducono l'espressione di TPO e Tireoglobulina in colture primarie di carcinoma indifferenziato della tiroide 116
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. 116
Trap1, a novel antiapoptotic gene responsible for multidrug resi stance in human colorectal carcinoma cells. 115
Modulazione della MnSOD con LPS e ferro in HCC di ratto. 114
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features 114
Amlexanox induces the reversible attenuation of F-acitin stress fibers. 113
"TRAP1 7-protein signature" predicts clinical outcome in human metastatic colorectal carcinoma 113
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of FGF1 in Response to Stress. 112
Cooperation between FGF1 and a soluble form of the notch ligand, Jagged-1, is required for a cell transformation. 112
Tripla modulazione del 5-Fluorouracile (5-FU) con Methotrexate (MTX), Acido Folinico (FA) e Cisplatino (CDDP) nella terapia dell’adenocarcinoma gastrico in fase avanzata: studio di fase II 111
TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways 111
Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report. 110
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 110
TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells 109
BRAF V600E and KRAS G12R mutations correlate with Sunitinib resistance in thyroid cancer cell lines. 109
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. 108
IRON REQUIREMENT FOR MnSOD GENE ACTIVATION IN MAMMALIAN CELLS. 108
Il Sunitinib inibisce la proliferazione di linee di carcinoma tiroideo BRAF e KRAS wild-type. 108
The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: comparison with the toxic effect on NAD(P)H:quinone reductase. 107
RE-INDUCTION OF CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR IN RESPONSE TO THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE 107
Meccanismi molecolari coinvolti nell’azione differenziante della nevirapina nel carcinoma indifferenziato della tiroide. 107
Adaptation to oxidative stress, chemoresistance and cell survival 106
PRECLINICAL EVIDENCES ON THE ACTIVITY OF EGFR1 INHIBITORS IN POORLY-DIFFERENTIATED THYROID CARCINOMA CELLS 106
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 106
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting 106
The levels of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanism and clinical implications. 105
bFGF LEVELS IN COLORECTAL CANCER: PRELIMINARY REPORT. 105
TRAP1, a novel antiapoptotic gene responsible for multidrug resistance. 104
Gli inibitori della retrotrascrittasi inducono il differenziamento cellulare e ripristinano la captazione di iodio nel carcinoma anaplastico della tiroide sia in vitro che in vivo 104
Aumentata espressione della manganese superossidodismutasi in tumori cerebrali neuroectodermici: un nuovo marcatore di progressione? 104
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 104
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 103
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma 103
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 103
The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock. 102
Biological mechanisms and clinical significance of angiogenesis in colorectal cancer. 101
TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: Relevance in human colorectal tumors. 101
Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography 101
Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer. 100
Diethyldithiocarbamate treatment up-regulates manganese superoxidedismutase gene expression in rat liver. 100
Preparation of a monoclonal antibody against rat MnSOD, using a COOH-terminal peptide. 100
Trap-1, a novel antiapoptotic gene responsible for resistance to chemotherapeutic agents in human colorectal carcinoma. 100
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. 100
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 100
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 100
S100A13 is a new angiogenic marker in human melanoma 99
Functional characterization of TRAP1 pathway in multidrug resistance in human colorectal carcinoma. 99
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS 99
TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review). 99
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. 98
Inhibition of cell proliferation by amlexanox correlates with cortactin phosphorylation and cyclin D1 down-regulation independent of MAPK activation. 98
Nevirapine restores hormone sensitivity in undifferentiated androgen-refractory prostate carcinoma cells 97
THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE RE-INDUCES CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR 97
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer 97
Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells 97
Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC. 96
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 96
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas. 96
Induction of MnSOD by ethanol administration in rat liver. 95
Sorcin induces a drug-resistant phenotype in human colorectal cancer through the modulation of Ca2+ homeostasis. 95
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 95
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 95
TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas 95
TMZ and PCV in unresectable high grade gliomas: a retrospective comparison between two common schedules. 94
Jagged-1-dependent cell chord formation in vitro is modified by src and is resistant to the destabilization of actin stress fibers. 94
Reverse transcriptase (RT) inhibitors down regulate tumor growth, induce cell differentiation and re-estabilish iodine uptake in human thyroid anaplastic carcinoma cells 94
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma 94
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas 94
Treatment of patients with advanced gastric carcinoma with 5-fluorouracil-based or cisplatin-based regimen: two parallel phase II studies. 93
Variation of MnSOD in rat experimental tumors detected by western blot analysis with a new monoclonal antibody. 93
Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation 93
The reciprocal regulation between TRAP1 and BRAF is responsible for control of cell cycle progression and modulation of mitochondrial apoptotic pathway. 93
MECHANISM OF DEFECTIVE GENE EXPRESSION OF MNSOD IN CANCER CELLS. 92
S100A13, a new marker of angiogenesis in brain tumors. 92
TRAP1 represent a key mediator of stemness and glycolytic metabolism in colorectal cancer cells 92
TRAP1 downregulation in human ovarian cancer enhances invasion and Epithelial-Mesenchymal Transition 92
Totale 10.816
Categoria #
all - tutte 132.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.092 0 0 0 0 0 133 297 84 273 279 4 22
2021/20221.192 193 11 15 19 60 20 37 99 177 119 51 391
2022/20235.757 467 210 271 341 384 541 58 438 2.740 35 124 148
2023/2024971 187 42 58 44 100 285 39 68 5 19 4 120
2024/20254.228 162 99 78 194 173 580 497 283 1.025 256 395 486
2025/20263.630 478 701 821 922 437 271 0 0 0 0 0 0
Totale 23.756